This article highlights key applications, clinical trial developments, and regulatory classifications of NAD? and its derivatives across major global markets.
Renue by Science?, a global leader in NAD+ precursor supplements, is excited to announce the official launch of its highly anticipated skincare range, Renue Blue?.
Penn Medicine researchers have solved a decades old mystery around a key molecule fueling the power plant of cells that could be exploited to find new ways to treat diseases, from neurodegenerative disorders to cancer.